Angiodynamics Inc financial data

Symbol
ANGO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
14 Plaza Drive, Latham, NY
State of incorporation
DE
Fiscal year end
May 31
Latest financial report
10-Q - Q1 2025 - Apr 2, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 213 % -9.74%
Quick Ratio 76.1 % -2.33%
Debt-to-equity 53.4 % +79%
Return On Equity -21.4 % +60.4%
Return On Assets -13.9 % +66.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.6M shares +1.38%
Common Stock, Shares, Outstanding 41M shares +1.35%
Entity Public Float 227M USD -49.7%
Common Stock, Value, Issued 385K USD 0%
Weighted Average Number of Shares Outstanding, Basic 40.9M shares +1.54%
Weighted Average Number of Shares Outstanding, Diluted 40.9M shares +1.54%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 283M USD -12.6%
Research and Development Expense 26.4M USD -19.3%
Selling and Marketing Expense 101M USD -3.11%
General and Administrative Expense 42.3M USD +3.29%
Operating Income (Loss) -48.6M USD +75.5%
Nonoperating Income (Expense) 5.57M USD +3467%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -42.1M USD +78.9%
Income Tax Expense (Benefit) -671K USD +90.4%
Net Income (Loss) Attributable to Parent -41.4M USD +78.5%
Earnings Per Share, Basic -1.03 USD/shares +78.5%
Earnings Per Share, Diluted -1.03 USD/shares +78.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44.8M USD -42.9%
Accounts Receivable, after Allowance for Credit Loss, Current 43.5M USD -12.1%
Inventory, Net 63.1M USD +8.67%
Assets, Current 172M USD -12.5%
Property, Plant and Equipment, Net 32.5M USD -12.2%
Operating Lease, Right-of-Use Asset 4.3M USD +11.5%
Intangible Assets, Net (Excluding Goodwill) 70.9M USD -13%
Goodwill 0 USD -100%
Other Assets, Noncurrent 9.68M USD +3.82%
Assets 285M USD -12.1%
Accounts Payable, Current 30.3M USD -13.9%
Employee-related Liabilities, Current 18.5M USD +37.5%
Accrued Liabilities, Current 36.9M USD +19.3%
Liabilities, Current 78M USD -9.2%
Operating Lease, Liability, Noncurrent 2.57M USD +10.7%
Other Liabilities, Noncurrent 17.4M USD +21%
Liabilities 99.5M USD -6.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.53M USD -25.9%
Retained Earnings (Accumulated Deficit) -423M USD -10.8%
Stockholders' Equity Attributable to Parent 186M USD -15%
Liabilities and Equity 285M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.3M USD +29.5%
Net Cash Provided by (Used in) Financing Activities -509K USD +99.1%
Net Cash Provided by (Used in) Investing Activities -2.41M USD -102%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 41.6M shares +1.94%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -21.1M USD -262%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 44.8M USD -42.9%
Deferred Tax Assets, Valuation Allowance 52.7M USD +105%
Deferred Tax Assets, Gross 56.3M USD -5.87%
Operating Lease, Liability 4.4M USD +10.8%
Payments to Acquire Property, Plant, and Equipment 1.09M USD +38.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42.1M USD +78%
Lessee, Operating Lease, Liability, to be Paid 4.71M USD +11.6%
Property, Plant and Equipment, Gross 108M USD +5.15%
Operating Lease, Liability, Current 1.83M USD +11%
Lessee, Operating Lease, Liability, to be Paid, Year Two 983K USD -31.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.97M USD +17.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -339K USD +97%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 313K USD +23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 729K USD +66.8%
Deferred Tax Assets, Operating Loss Carryforwards 28.2M USD -30.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 729K USD +94.4%
Operating Lease, Payments 562K USD +5.64%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 10.3M USD -30.8%
Share-based Payment Arrangement, Expense 10M USD -13.2%
Interest Expense -1.61M USD -160%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%